Adam Mcananey Biography and Net Worth

Insider of Oscar Health

Adam McAnaney is the Chief Legal Officer at Oscar, where he oversees the company's Legal, Compliance, and Regulatory functions.

Prior to Oscar, Adam served as Chief Legal Officer and Secretary at Monogram Health, a leading value-based provider of in-home, evidence-based care and benefit management services for patients living with polychronic conditions.

Before joining Monogram Health, Adam served as General Counsel and Secretary for Signify Health, following its acquisition of Remedy Partners. Prior to joining Remedy Partners as General Counsel and Secretary, Adam led multiple strategic initiatives at Aetna, serving as Vice President, Head of Corporate Legal and Corporate Secretary. Prior to assuming leadership roles at Aetna, Adam worked in the New York, Frankfurt, and London offices of Sullivan & Cromwell LLP, where he focused on capital markets and mergers and acquisitions. Adam holds a JD from Columbia Law School as well as a BA from Yale University.

What is Adam Mcananey's net worth?: The estimated net worth of Adam Mcananey is at least $3.14 million as of December 2nd, 2025. Mcananey owns 179,241 shares of Oscar Health stock worth more than $3,144,783 as of January 15th. This net worth approximation does not reflect any other investments that Mcananey may own. Learn More about Adam Mcananey's net worth.
How do I contact Adam Mcananey?: The corporate mailing address for Mcananey and other Oscar Health executives is 75 Varick Street 5th Floor, New York NY, 10013. Oscar Health can also be reached via phone at 646-403-3677 and via email at [email protected]. Learn More on Adam Mcananey's contact information.
Has Adam Mcananey been buying or selling shares of Oscar Health?: Adam Mcananey has not been actively trading shares of Oscar Health during the last ninety days. Most recently, Adam Mcananey sold 1,852 shares of the business's stock in a transaction on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a transaction totalling $30,724.68. Following the completion of the sale, the insider now directly owns 179,241 shares of the company's stock, valued at $2,973,608.19. Learn More on Adam Mcananey's trading history.
Who are Oscar Health's active insiders?: Oscar Health's insider roster includes Victoria Baltrus (CAO), Richard Blackley (CFO), Ranmali Bopitiya (EVP), Meghan Joyce (COO), Joshua Kushner (Vice Chairman), Adam Mcananey (Insider), Alessandrea Quane (EVP), Elbert Robinson, Jr. (Director), Sid Sankaran (Director), Mario Schlosser (CEO), Dennis Weaver (Insider), and Steven Wolin (COO). Learn More on Oscar Health's active insiders.
Are insiders buying or selling shares of Oscar Health?: During the last twelve months, insiders at the sold shares 10 times. They sold a total of 903,307 shares worth more than $15,325,899.56. The most recent insider tranaction occured on January, 8th when insider Mario Schlosser sold 23,038 shares worth more than $406,620.70. Insiders at Oscar Health own 24.4% of the company. Learn More about insider trades at Oscar Health.
Information on this page was last updated on 1/8/2026.

Adam Mcananey Insider Trading History at Oscar Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/2/2025	Sell	1,852	$16.59	$30,724.68	179,241

Adam Mcananey Buying and Selling Activity at Oscar Health

Oscar Health Company Overview

Oscar Health, Inc. operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

Today's Range

Now: $17.91

$16.32

$18.20

50 Day Range

MA: $15.80

$13.03

$18.13

2 Week Range

Now: $17.91

$11.20

$23.80

Volume

8,383,177 shs

Average Volume

8,840,593 shs

Market Capitalization

$4.74 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.9